Therapeutic Use of Angiopoietin-Primed Autologous Peripheral Blood Stem Cell in Myocardial Infarction

NCT06364150 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

30

Enrollment

OTHER_GOV

Sponsor class

Conditions

Acute Myocardial Infarction

Interventions

BIOLOGICAL: Autologous Peripheral Blood Stem Cell injection

Sponsor

Seoul National Hospital

Collaborators

[object Object]